| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1
Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263
The capacity of recombinant human interleukin 2 (rH-IL2), alone or in combination with recombinant tumor necrosis factor (r-TNF
), to activate murine resident peritoneal macrophages to a tumoricidal state was examined. Resident peritoneal exudate cells from C57BL/6 mice were cultured for 18 h with activating agents and washed and the adherent cells (macrophages) were assessed for cytolytic activity against radiolabeled target tumor cells (EL4, P815). Under these conditions, rH-IL2 alone activated macrophages to a tumoricidal state in a concentration dependent fashion. Neither murine nor human r-TNF
alone had any activating effect but, when combined with rH-IL2, further stimulated rH-IL2-inducible responses. Using polymyxin B, it was shown that macrophage activation was not due to an inadvertent lipopolysaccharide contamination of the r-TNF
or rH-IL2 preparations. It was also unlikely that target cell lysis was a direct result of increased TNF
production by rH-IL2 stimulated macrophages since P815 is totally resistant to lysis by r-TNF
. Although the lytic effector function was mediated by adherent cells, nonadherent peritoneal exudate cells were required for activation to occur. Furthermore, antisera against murine
-interferon, when added to activation cultures, reduced the level of cytolytic activity which developed. These data suggest that rH-IL2-induced peritoneal macrophage activation requires stimulation of nonadherent cells and is dependent upon
-interferon mediated mechanisms.
1 Supported in part by Grants CA-15142, CA-13038, CA-24538, and CA-16056, awarded by the National Cancer Institute, Department of Health and Human Services, and a travel stipend awarded to S. V. by the Croatian Ministry of Science.
2 Medical student, School of Medicine, University of Zagreb, Zagreb, Croatia. Studies carried out during summer visits to Roswell Park Cancer Institute.
3 To whom requests for reprints should be addressed.
Received 1/27/92. Accepted 5/ 6/92.
This article has been cited by other articles:
![]() |
Z. Li, F. Pradera, T. Kammertoens, B. Li, S. Liu, and Z. Qin Cross-Talk between T Cells and Innate Immune Cells Is Crucial for IFN-{gamma}-Dependent Tumor Rejection J. Immunol., August 1, 2007; 179(3): 1568 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Murphy, S. Sommer, E. A. Kabara, N. Verman, M. A. Kuelbs, P. Saama, R. Halgren, and P. M. Coussens Gene expression profiling of monocyte-derived macrophages following infection with Mycobacterium avium subspecies avium and Mycobacterium avium subspecies paratuberculosis Physiol Genomics, December 13, 2006; 28(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Puddu, M. Carollo, I. Pietraforte, F. Spadaro, M. Tombesi, C. Ramoni, F. Belardelli, and S. Gessani IL-2 induces expression and secretion of IFN-{gamma} in murine peritoneal macrophages J. Leukoc. Biol., September 1, 2005; 78(3): 686 - 695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |